Free Trial

G2 Investment Partners Management LLC Acquires New Shares in Semler Scientific, Inc. (NASDAQ:SMLR)

Semler Scientific logo with Medical background

G2 Investment Partners Management LLC bought a new stake in Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 30,576 shares of the company's stock, valued at approximately $1,651,000. G2 Investment Partners Management LLC owned 0.33% of Semler Scientific at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in SMLR. Veery Capital LLC acquired a new stake in shares of Semler Scientific during the fourth quarter valued at about $324,000. Exchange Traded Concepts LLC boosted its holdings in Semler Scientific by 345.8% in the fourth quarter. Exchange Traded Concepts LLC now owns 61,396 shares of the company's stock valued at $3,315,000 after purchasing an additional 47,625 shares during the last quarter. Deltec Asset Management LLC acquired a new stake in Semler Scientific during the 4th quarter valued at approximately $2,462,000. Principal Financial Group Inc. increased its holdings in Semler Scientific by 633.1% during the 4th quarter. Principal Financial Group Inc. now owns 112,487 shares of the company's stock worth $6,074,000 after purchasing an additional 97,144 shares during the last quarter. Finally, Sanctuary Advisors LLC raised its position in shares of Semler Scientific by 13.2% in the 4th quarter. Sanctuary Advisors LLC now owns 5,012 shares of the company's stock valued at $261,000 after purchasing an additional 584 shares in the last quarter. 49.37% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Lake Street Capital raised their price target on shares of Semler Scientific from $40.00 to $71.00 and gave the stock a "buy" rating in a research report on Friday, January 24th.

View Our Latest Research Report on SMLR

Semler Scientific Stock Down 1.3%

Shares of SMLR traded down $0.45 during midday trading on Friday, hitting $34.79. The company had a trading volume of 489,843 shares, compared to its average volume of 426,605. The stock has a market cap of $333.88 million, a price-to-earnings ratio of 7.09 and a beta of 1.33. The company's 50 day moving average price is $35.05 and its 200 day moving average price is $46.74. Semler Scientific, Inc. has a 52 week low of $21.77 and a 52 week high of $81.56.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last announced its quarterly earnings data on Tuesday, February 18th. The company reported $3.41 earnings per share for the quarter, beating the consensus estimate of $0.20 by $3.21. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%. The firm had revenue of $12.41 million during the quarter.

About Semler Scientific

(Free Report)

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Read More

Institutional Ownership by Quarter for Semler Scientific (NASDAQ:SMLR)

Should You Invest $1,000 in Semler Scientific Right Now?

Before you consider Semler Scientific, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.

While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Spring 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines